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Objectives: This paper presents a methodology for recovering and decomposing Swanson’s Raynaud Syn-
drome–Fish Oil hypothesis semi-automatically. The methodology leverages the semantics of assertions
extracted from biomedical literature (called semantic predications) along with structured background
knowledge and graph-based algorithms to semi-automatically capture the informative associations orig-
inally discovered manually by Swanson. Demonstrating that Swanson’s manually intensive techniques
can be undertaken semi-automatically, paves the way for fully automatic semantics-based hypothesis
generation from scientiﬁc literature.
Methods: Semantic predications obtained from biomedical literature allow the construction of labeled
directed graphs which contain various associations among concepts from the literature. By aggregating
such associations into informative subgraphs, some of the relevant details originally articulated by Swan-
son have been uncovered. However, by leveraging background knowledge to bridge important knowl-
edge gaps in the literature, a methodology for semi-automatically capturing the detailed associations
originally explicated in natural language by Swanson, has been developed.
Results: Our methodology not only recovered the three associations commonly recognized as Swanson’s
hypothesis, but also decomposed them into an additional 16 detailed associations, formulated as chains
of semantic predications. Altogether, 14 out of the 19 associations that can be attributed to Swanson were
retrieved using our approach. To the best of our knowledge, such an in-depth recovery and decomposi-
tion of Swanson’s hypothesis has never been attempted.
Conclusion: In this work therefore, we presented a methodology to semi-automatically recover and
decompose Swanson’s RS-DFO hypothesis using semantic representations and graph algorithms. Our
methodology provides new insights into potential prerequisites for semantics-driven Literature-Based
Discovery (LBD). Based on our observations, three critical aspects of LBD include: (1) the need for more
expressive representations beyond Swanson’s ABC model; (2) an ability to accurately extract semantic
information from text; and (3) the semantic integration of scientiﬁc literature and structured background
knowledge.
Published by Elsevier Inc.1. Introduction
Literature-Based Discovery (LBD) is characterized by uncover-
ing hidden but novel information implicit in noninteracting litera-
tures. The ﬁeld was pioneered by Don R. Swanson in 1986, through
the well-known Raynaud Syndrome-Fish Oil hypothesis (RS-DFO)
[1]. Swanson serendipitously observed that dietary ﬁsh oils (DFO)
appear to lower blood viscosity, reduce platelet aggregation and in-Inc.hibit vascular reactivity (speciﬁcally vasoconstriction). Concomi-
tantly, a reduction in blood viscosity and platelet aggregation,
and the inhibition of vascular reactivity appeared to prevent Ray-
naud Syndrome (RS); a circulatory disorder that causes periods of
severely restricted blood ﬂow to the ﬁngers and toes [2]. Swanson
therefore postulated that ‘‘dietary ﬁsh oil might amelioriate or pre-
vent Raynaud’s syndrome.’’
Remarkably, explicit associations between DFO and these inter-
mediate concepts (i.e., blood viscosity, platelet aggregation and
vascular reactivity) had long existed in the literature. Likewise, ex-
plicit associations between the intermediate concepts and RS had
been well documented. The serendipity in Swanson’s hypothesis
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been previously articulated. To arrive at this discovery, in Novem-
ber 1985, Swanson obtained an initial seed set of 489 articles and
performed a Dialog Scisearch using Raynaud and Fish Oil terms,
on titles and abstracts of MEDLINE and Embase (Excepta Medica)
citations. He found that among the 489 articles, only four articles
contained cross-references spanning both the DFO and RS group.
Among these four articles, he found that only two [3,4] were asso-
ciated with both RS and DFO. Swanson speculated that this phe-
nomenon of noninteracting literatures, alludes to the existence of
undiscovered public knowledge [5]. He exploited his awareness of
the existence of such undiscovered semantic associations [6] across
noninteracting literatures and investigated several other scenarios
[7–11] (along with Smalheiser) that later led to new scientiﬁc
discoveries.
Swanson grounded his observations in a paradigm refered to as
the ABC model [1]. This model states that new knowledge can be
discovered between two concepts (A,C) from noninteracting litera-
tures, if hidden associations involving some intermediate concept
(B) can be uncovered. This seminal model has revolutionized the
ﬁeld of LBD, and has been used both to recover many of Swanson’s
original hypotheses [12–18] as well as to propose new hypotheses
[19,17,20,21].
However, while Swanson did indeed provide detailed explana-
tions for his observations, he presented no discussion on a frame-
work for ﬁnding such details, automatically or otherwise. Instead,
Swanson’s ABCmodel has been used extensively to arrive at high-le-
vel conclusions. Hence, much of the early LBD research [22] used IR
techniques [13,12,21,23–25] to illustrate the effectiveness of the
ABC model for LBD. The Arrowsmith search tool [23,24], developed
by Smalheiser and Swanson, epitomizes LBD achieved using this
ABC-IR framework. The underlying philosophy behind ABC-IR has
been that, in scenarios in which both source (A) and target (C) are
known (closed discovery), new discoveries will arise from intermedi-
ates that ‘frequently co-occur’ with source and target. Hence, tech-
niques such as surface form normalization [25,14], text-to-concept
mapping [16,14,25], term counts and relative frequencies
[13,12,25] have been used extensively for ﬁnding and ranking inter-
mediates. The main issue with term co-occurrence approaches how-
ever, (whether strictly lexical or concept-based) is that while they
often succeed in ﬁnding intermediate (B) concepts, they provide
no insight into the nature of the relationships among such concepts.
For example, while the terms ‘‘DFO,’’ ‘‘platelet aggregation’’ and ‘‘RS’’
may frequently co-occur in some corpus, their co-occurrence does
not explicitly reﬂect the association that (DFO INHIBITS platelet
aggregation) and an increase in (platelet aggregation CAUSES RS).
This limitation has far reaching implications in the biomedical
domain. Smalheiser [26] recently noted that next generation LBD
requires more expressive representations beyond the ABC model.
Ahlers et al. [19] makes the speciﬁc observation that in treatment
of diseases for example, ‘‘Drug therapies are often used effectively,
even though the exact cause of action may be either poorly understood
or unknown.’’ Biomedical researchers are therefore not only inter-
ested in mere co-occurrence relationships, but also in understand-
ing the mechanisms of interaction and causality relationships
among concepts. In the previous example (p1), the detailed
association that p1 = (DFO STIMULATES Epoprostenol)? (Epoprost-
enol ISA Prostaglandin? (Prostaglandin INHIBITS platelet aggrega-
tion)? (platelet aggregation CAUSES RS) is of more interest to
researchers because it conveys causality.
IR techniques therefore may fail to provide context and domain
semantics in such critical scenarios. Other approaches, including
those based on techniques such as Latent Semantic Indexing [27]
and concept-based link analysis [14,28] also suffer the same draw-
back. Approaches based entirely on the ABC paradigm and the idea
that one level of intermediates is sufﬁcient for LBD, offer limitedcoverage across the relevant associations to the discourse. Natu-
rally, relevant information may exist in longer chains of concepts
semantically connected.
Semantics-based approaches to LBD [19,17,18,29,20] therefore
aim to provide context as well as improve coverage. To achieve this,
they rely on assertions (or semantic predications) extracted from the
literature. Semantic predications are binary relations of the form
(subject, predicate, object), where the predicate expresses a relation-
ship between the subject and the object. For example, in the seman-
tic predication (DFO INHIBITS platelet aggregation), the predicate
‘‘INHIBITS’ expresses the relationship between the subject ‘‘DFO’’
and the object ‘‘platelet aggregation.’’ Wilkowski et al. [20] was
among the ﬁrst to demonstrate the inherent value in using semantic
predications to move LBD beyond the canonical ABC model. With-
out loss of generality, Wilksowski proposed that the ABC model
can be decomposed into a more granular model in which several
intermediate concepts may be required to expound associations.
We refer to Wilkowski’s logical extension of Swanson’s ABC model,
as the AnC model (pronounced ants), in which n = (B1,B2, . . . ,Bm).
While more expressive than the ABC model, the AnC model itself
is not foolproof. Consider an extension of the previous example
(p1), consisting of two associations ðp2; p3Þ instead of one. Suppose
the ﬁrst association states that p2 = (DFO STIMULATES Epoprost-
enol)? (Epoprostenol TREATS RS) and the second states that
p3 = (DFO CONVERTS_TO Prostaglandin (PGI3))? (Prostaglandin
(PGI3) INHIBITS platelet aggregation)? (platelet aggregation CAUSES
RS). Further, suppose that these two associations ðp2; p3Þ, along
with the association from the previous example ðp1Þ and a host
of other associations ðp4; p5Þ, . . ., pi are part of a labeled graph of
semantic predications (called a predications graph). These two asso-
ciations ðp2; p3Þ, connected by their common vertices in this pred-
ications graph, will naturally form a subgraph (Fig. 1, left).
However, unlike example ðp1Þ, in this scenario the role of Epoprost-
enol and platelet aggregation together, in treating RS has now been
obscured. Instead, it requires background knowledge (whether
from structured sources or from domain experts) to bridge the
gap and provide the semantic predication which states that (Pros-
taglandin (PGI3) ISA Epoprostenol). Given this additional informa-
tion from background knowledge, we can then conclude through
transitivity that there exists at least one instance in which an Epo-
prostenol, namely (Prostaglandin (PGI3) INHIBITS platelet aggrega-
tion), is the mechanism for treating RS (Fig. 1, right). From this
example, it is clear that while both the ABC model and the AnC
model may be sufﬁcient for LBD, the construction of relevant sub-
graphs that leverage background knowledge (as in Fig. 1) play a
critical role in supplementing and complementing both models.
This example highlights the ﬁrst and third points put forth in the
Conclusion Section of the abstract, which state that the future of
semantics-based LBD requires: (1) more expressive representations
beyond Swanson’s ABC model and also (3) the semantic integration
of scientiﬁc literature and structured background knowledge.
In this work, we therefore investigate the use of semantic pred-
ications, semantic associations, expressive subgraphs and back-
ground knowledge for LBD, using graph-based techniques. We
make the following speciﬁc contributions:
 We are the ﬁrst to conduct a detailed decomposition of Swan-
son’s RS-DFO hypothesis into 19 associations, compared with
recovery approaches limited to only the three well known
associations.
 Similar to Wilkowski, we extend the classical ABC model into a
more expressive model which we term the AnC model, leveraged
for semantic association generation. The expressive associations
resulting from this extension provide detailed explanations
needed to understand the causality relationships and mecha-
nisms of interaction among concepts.
Fig. 1. From associations to subgraph to background knowledge.
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associations, especially in scenarios when associations alone
are not sufﬁciently expressive to adequately expound connec-
tions among concepts.
 Finally, we show that when subgraphs themselves are not suf-
ﬁciently expressive, semantically integrating background
knowledge to bridge knowledge gaps in the scientiﬁc literature
is crucial for LBD.
2. Related work
Hristovski was among the ﬁrst to present ideas advocating the
use of semantic predications for LBD. His pattern-based approach
[17,30] leverages both semantics (from SemRep [31]) and term
co-occurrence (from BioMedLEE [32]) to recover existing knowl-
edge as well as to suggest new relationships between concepts.
He uses discovery patterns speciﬁed a priori, to ﬁnd potentially
interesting associations. For example, if some disease (A) and some
drug (C) have opposing effects on the same intermediate concept
(B) then he speculates that drug (C) Maybe_Treats disease (A). In
the case of the RS-DFO hypothesis, since DFO ‘‘reduces’’ blood vis-
cosity and platelet aggregation, and RS occurs when blood viscosity
and platelet aggregation levels increase, Hristovski infers that DFO
Maybe_Treats RS. The ‘‘reduces-increases’’ pattern is used to imply
Maybe_Treats. The limitation of Hristovski’s pattern-based ap-
proach is that it cannot be easily extended to accommodate com-
plex patterns. In fact, since the patterns are restricted to the
proverbial ABC paradigm, interesting and more complex associa-
tions will go undetected.
Ahlers et al. [19] also applies semantic predications to LBD,
leveraging Hristovski’s idea of discovery patterns. Under the ABC
paradigm they infer the Maybe_Disrupts predicate. The argument
is that, an antipsychotic drug (A)Maybe_Disrupts cancer if the drug
(A) INHIBITS some intermediate bioactive, pathological and/or
pharmacologic concept (B) which CAUSES, PREDISPOSES or is ASSO-
CIATED_WITH cancer (C). The ‘inhibits-causes’ pattern is used to in-
ferMaybe_Disrupts. Ahlers discovered ﬁve interesting intermediate
concepts relating antipsychotic drugs and cancer using this pat-
tern. In this work, we eliminate the need to know and specify dis-
covery patterns a priori by implementing a graph traversal
algorithm agnostic to speciﬁc patterns.
Aside from pattern-based approaches, some discovery support
systems use various heuristics to provide focused search and brows-
ing to support semantics-based LBD. Cohen et al. [29] implemented
Epiphanet, which visualizes associations of varying lengths
between concepts based on chains of predications between them.
Epiphanet uses the notion of random reﬂexive indexing (RRI) to
establish connections between concepts that do not necessarily
co-occur in text but are related in the corpus, based on normalizing
lexical variants. We tested the ‘‘logical leap’’ feature of Epiphanet
with DFO variants (i.e., the UMLS concepts Fish oil – dietary
(FOD), Fish Oils (FO) and Eicosapentaenoic Acid (EPA)) as the sourceand Raynaud Phenomenon (RP) as the target. Unfortunately no
associations were found that directly connected source and target.
In previous work, we [33] implemented a discovery support
system, later enhanced by Kavuluru et al. [34] and called Scooner,
that also leverages structured knowledge to facilitate LBD. Users
can perform assertion-driven (semantic) browsing by ﬁrst select-
ing one or more annotated concepts/subjects from one MEDLINE
article, then selecting a relevant predicate (p) for which (s) is the
subject, and ﬁnally selecting an object (o) grounded in a different
MEDLINE article. LBD may occur after users analyze associations
or semantic trails created through such contextual navigation. We
tested Scooner with Eicosapentaenoic Acid (EPA) as the source
and Raynaud Disease (RD) as the target and were unable to recover
Swanson’s hypothesis within a reasonable time frame. We
acknowledge that while the potential for replicating Swanson’s
RS-DFO hypothesis may exist using Scooner, our efforts to do so
in this particular scenario were unsuccessful.
Pratt and Yetisgen-Yildiz [16,28] implemented a system called
LitLinker that uses UMLS concepts, UMLS semantic network types
and the idea of level of support for open discovery. In open discovery
only the starting concept and some intermediate are known, but
not the target. By eliminating irrelevant intermediate concepts
(i.e., linking concepts), based on low level of support from the cor-
pus, Pratt successfully retrieved several intermediate concepts
from Swanson’sMagnesium-Migraine hypothesis [7]. She ﬁrst mea-
sured the support for linking concepts by estimating its likelihood
based on the number of titles containing it in the corpus, and then
ﬁlter target concepts (under the ABC paradigm) based on the cen-
trality score of their linking concepts. This approach may lack cov-
erage, since ranking target concepts based on centrality scores may
eliminate interesting but rarely mentioned intermediate concepts.
Our graph-based approach that leverages semantics is more ﬂexi-
ble and adaptable to ensure better coverage than Pratt’s approach.
Wilkowski et al. [20] also proposed graph-based ideas for open
discovery using the notion of discovery browsing together with de-
gree centrality using the predications graph. Discovery browsing
seeks to present users with discovery patterns in a user-friendly
way. This is achieved by ranking predications according to the de-
gree centrality of their subject and object. Ideally, a user can tra-
verse the predications graph by visiting high centrality vertices
(predications) in succession. Similar to Pratt [16] however, Wil-
kowski’s approach may eliminate interesting outliers. Note that
Wilkowski was the ﬁrst to materialize an extension of the ABC
model in which the intermediate concept (B) was a set, instead
of just a single concept.
In previous work, we [35] also describe a graph-theoretic appli-
cation of the predications that has implications on Question
Answering (QA) as well as LBD. By using the predications to con-
nect documents that answer complex questions, they suggest that
associations may inherently contain knowledge that could lead to
new scientiﬁc hypotheses. They use a modiﬁed depth ﬁrst search
(MDFS) algorithm along with various heuristics to make logical
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leverages semantic relatedness among concepts from background
knowledge; a theme reiterated here.
Finally, Hristovski implemented a discovery support system
called BITOLA [18] that also leverages graph theory and term co-
occurrence statistics for LBD. BITOLA is applicable in both closed
and open discovery scenarios. It uses conﬁdence and evidence-
based support to rank pairs of concepts from corpus statistics. We
tested BITOLA for closed discovery using Eicosapentaenoic Acid
(EPA) as the source, Raynaud Disease (RD) as the target, and with
‘‘Cell Function’’ as the a priori semantic type of the intermediate.
We found the intermediates, ‘‘platelet aggregation’’ and ‘‘erythro-
cyte deformability’’ as the #1 and #2 ranked concepts respectively,
among only 24 intermediates. This result is very impressive. We
then tested BITOLA for open discovery using EPA as the source,
‘‘blood viscosity’’ as the intermediate and ‘‘Eicosanoid’’ as the
semantic type for the target. We found the target Epoprostenol
at position 3 out of 21, which is also remarkable. The problem is
that ‘‘Epoprostenol’’ cannot be further explored without construct-
ing another query. This restriction is due to the ABC model. As evi-
denced by the role of ‘‘Epoprostenol,’’ ‘‘Prostaglandins’’ and
‘‘platelet aggregation’’ in treating RS (discussed in Section 1
Fig. 1), provisions for exploring more detailed associations is essen-
tial. We believe this scenario corroborates the need for the AnC
model, to better explicate associations between concepts.3. Method
Our graph-based framework for recovering and decomposing
Swanson’s RS-DFO hypothesis involves ﬁve tasks; (1) literature
selection and preprocessing; (2) semantic predication extraction
from the selected literature; (3) building the predications graph
from the extracted semantic predications; (4) applying a search
algorithm for semantic association generation; and (5) subgraph
creation using relevant associations, and background knowledge
where appropriate. We begin by discussing literature selection
and preprocessing in the next Section.1 Datasets – http://wiki.knoesis.org/index.php/Obvio#RS-DFO_Hypothesis.
2 SKR Web API-http://skr.nlm.nih.gov/SKR_API/.3.1. Literature selection and preprocessing
The sixty-ﬁve articles cited in Swanson’s original RS-DFO paper
[1] were selected as the baseline dataset for our approach. Such a
minimal dataset was selected mainly because we are interested
in assessing the feasibility of using semantic predications, semantic
associations, expressive subgraphs, background knowledge and
graph algorithms for recovering an existing hypothesis.
We believe that if our techniques can be successfully applied to
rediscover existing knowledge, then moving from rediscovery to
actual knowledge discovering will require a recalibration of our ap-
proaches to deal mainly with scalability. Proving that existing
knowledge can be recovered on a controlled dataset is an impor-
tant initial step in devising techniques that will be effective on lar-
ger heterogeneous datasets. Hence, we created a minimum
baseline of the 65 articles cited in the original RS-DFO paper, col-
lected, by manually searching PubMed, Google Scholar, Mendeley,
Wiley Online Library, Science Direct, etc. for abstracts and full text
articles. Altogether, one article (citation #60) was not found at all,
while another article was written in French (citation #64),
although an English version consisting of its title and abstract
was retrieved from PubMed. Twelve articles consisted of titles
and abstracts only (citation #4, 5, 22, 23, 25, 27, 37, 40, 43, 51,
57, 63), and ﬁve articles (citation #1, 8, 46, 56, 59) contained only
titles and full text but no abstract. We subdivided this initial base-
line into two sets. Baseline 1 (B1) consisted of titles, abstracts and
full text of all articles while Baseline 2 (B2) consisted of only titlesand abstracts of all articles. The choice of the two datasets was
motivated by the desire to determine, to what extent titles and ab-
stracts may be adequate for supporting LBD. Since MEDLINE pro-
vides only titles and abstracts for approximately 21 million
scientiﬁc papers, this was an important undertaking.
Since many articles in the B1 dataset were images rather than
text, we used an optical character recognition (OCR) text extractor
called The Tesseract OCR engine [36] to convert PDF articles to text.
We then converted nonASCII characters to ASCII, since tesseract
did not always accurately parse nonASCII characters (such as a).
A resulting subtask was the need to resolve end-of-line hyphen-
ation and text wrapping. For instance, the word ‘‘polyunsaturated’’
could be expressed as ‘‘polyunsatur-nnated’’ if it appears at the end
of a line in the PDF version of the article. Since it is necessary to dis-
tinguish between standard hyphenated words and those originat-
ing from PDF text wrapping, we obtained frequency counts for
hyphenated words in the corpus. We then removed hyphens from
words that were end-of-line words that fell below some empiri-
cally observed threshold frequency (threshold = 5). On the contrary,
since the B2 dataset was collected from PubMed, neither the con-
version to ASCII nor text wrapping issues surfaced while creating
that dataset.
Due to space limitations, only some datasets and experimental
results are listed in this manuscript. All datasets and experimental
results are available online.1 In the next Section we discuss how the
semantic predications were extracted using these two baseline data-
sets B1 and B2.
3.2. Predication extraction
Work on semantic predication extraction spans more than two
decades of research by Thomas C. Rindﬂesch at NLM. The linguis-
tics-based semantic predication extractor called SemRep, is now
available as a web service exposed by NLM, through the Semantic
Knowledge Representation (SKR) project. An abbreviated version of
the SemRep output is given below, applied to title of a MEDLINE
article [PMID6130329]:
Text—Intermittent epoprostenol (prostacyclin) infusion in
patients with Raynaud’s syndrome.
entity—C0205267—Intermittent—Intermittent
entity—C0033567—Epoprostenol—epoprostenol
entity—C0033567—Epoprostenol—prostacyclin
entity—C0574032—Infusion procedures—infusion
entity—C0030705—Patients—patients
entity—C0034734—Raynaud Disease—Raynaud’s syndrome
predication—Infusion procedures—TREATS—Patients
predication—Raynaud Disease—PROCESS_OF—Patients
predication—Infusion procedures—TREATS (INFER)—Raynaud
Disease
Note that the labels ‘‘epoprostenol’’ and ‘‘prostacyclin’’ in the
title, were both normalized to the concept ‘‘Epoprostenol
(C0033567)’’ among the recognized entities in lines 3 and 4 of
the output. We used the SKR Web API2 to access SemRep to extract
semantic predications from the baseline datasets. Extracted seman-
tic predications were subsequently used to build the predications
graphs.
3.2.1. Postprocessing
We made the following observation while processing the
SemRep output. SemRep erroneously parses the phrase ‘‘vascular
Table 1
Dataset and predications graphs.
Dataset #Semantic predications #Entities
B1: Full text 4438 1078
B2: Title/abstract 389 193
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C1660757)) into two tokens: (1) the ﬁrst is ‘‘Vascular,’’ which maps
to UMLS concept (Blood Vessels-C0005847) and (2) the second is
‘‘Reactivity,’’ which maps to UMLS concept (Reactive-C0205332).
This problem was ﬁrst detected by Hristovski et al. in their
attempts at rediscovering Swanson’s RS-DFO hypothesis [17,30].
Consequently, Hristovski only reported results on platelet aggrega-
tion and blood viscosity and ignored vascular reactivity altogether.
We realized that there were only 26 unique mentions of vascular
reactivity (and its lexical variants) in this corpus. Hence, we
manually augmented the SKR output with semantic predications
SemRep failed to extract. Such semantic predications are distin-
guished by appending the postﬁx ‘‘_MAN’’ to their UMLS predi-
cates. For example, INHIBITS_MAN represents the manually
identiﬁed UMLS predicate INHIBITS.
This action provided us the ﬂexibility to ﬁrst normalize the
UMLS concept ‘‘vascular reactivity’’ to UMLS concept (Vascular
constriction (function)-C0042396), since Swanson uses vascular
reactivity in his manuscript [1] in reference to vasoconstriction.
Further, since vasoconstriction and vasodilation convey opposite
semantics, for each mention of vasoconstriction we added another
semantic predication for vasodilation, containing the negating
predicate, and vice versa. For example, since (Epoprostenol INHIB-
ITS vasoconstriction) we included the semantic predication which
states that (Epoprostenol CAUSES vasodilation) which has the
negating predicate CAUSES for the predicate INHIBITS. From the
manual annotations to vascular reactivity dataset (also available
online), we obtained 76 semantic predications from B1 but only
one from B2. Overall, our manual extraction highlights the second
point put forth in the Conclusion Section of the abstract, which
states that the future of semantics-based LBD warrants an ability
to accurately extract semantic information from text.
In the next Section, we discuss the formalism and construction
of the predications graphs using the SemRep extracted semantic
predications and those manually added from the vascular reactiv-
ity dataset.
3.3. Predications graph
We formally articulated the notion of a predications graph in
[35], but we revisit it here for completeness. Using set notation,
let SðdiÞ be the set of semantic predications associated with article
di. If t denotes a semantic predication in di and D is the set of all
articles fd1; d2; . . . ; dng then,
For any t ¼ ðst; pt; otÞ; let DðtÞ ¼ fdjt 2 SðdÞg ð1Þ
be the set of corresponding articles that contain the semantic pred-
ication t and S (D) be the set of all semantic predications associated
with articles in D. That is,
SðDÞ ¼
[jDj
i¼0
SðdiÞ: ð2Þ
The semantic predications in S (D) for a set of articles D naturally
form a directed labeled graph, denoted GSðDÞ, in which the subject
and object of each semantic predication is a vertex, and the predi-
cate is a labeled edge from subject to object. This graph is called
the predications graph.
Table 1 shows that the predications graph for B1 consisted of
4434 semantic predications and 1077 unique concepts, while the
predications graph for B2 contains 388 semantic predications and
193 unique concepts. Fortunately, such small graphs impose no
major demands for run-time optimizations to improve our search
algorithm. In the next Section, we revisit the notion of a semantic
association originally articulated by Anyanwu et al. [6,37], and dis-cuss the algorithm for extracting such semantic associations from
the predications graphs.
3.4. Semantic association generation
As established by the associations ðp1; p2; p3Þ in Example1, from
Fig. 1, Swanson’s ABC model may be insufﬁcient for LBD in cases
when complex relationships exist among concepts. Expressive
associations based on the AnC model are imperative if such com-
plex associations will be captured. However, extracting expressive
semantic associations that are relevant, interesting, plausible, and
intelligible from an arbitrary labeled predications graph, is not triv-
ial. Furthermore, the very notion of an association must be well
understood if we are to capture such associations. We therefore re-
visit the notion of a semantic association here, and then discuss an
approach for efﬁciently extracting them.
3.4.1. Semantic association
Anyanwu et al. [6,37] deﬁnes a semantic association between
two vertices ðv i;v jÞ in terms of property sequences and joined
property sequences in which the vertex ðv iÞ may be the origin of
a property sequence, and the vertex ðv jÞ may also be the origin
or terminus of another property sequence. Informally, a semantic
association is a path connecting concepts through labeled edges
in a directed graph, such that paths can be joined together on com-
mon vertices to give rise to more complex semantic associations.
However, Anyanwu’s deﬁnition does not make it explicit that a
semantic association may contain sequences of edges in any direc-
tion. Consider for example, the association which states that p4 -
= (Eicosapentaenoic Acid? INHIBITS? Vascular Constriction 
INHIBITS Nifedipine? TREATS? Raynaud Phenomenon). A plau-
sible conclusion is that (Eicosapentaenoic Acid TREATS Raynaud
Phenomenon) by inhibiting Vascular Constriction. We arrive at this
conclusion using Hristovski’s notion of a discovery pattern dis-
cussed in Section 2. Since Nideﬁpine has an inhibiting effect on
Vascular Constriction (in the opposing direction), and also TREATS
Raynaud Phenomenon, we can speculate that (Eicosapentaenoic
Acid Maybe_Treats Vascular Constriction), since it too INHIBITS
Vascular Constriction.
From this scenario, it is therefore clear that a semantic associa-
tion must allow sequences of edges in any direction, if we are to
truly capture informative associations. Such semantic associations
connect concepts, through labeled edges oriented in any direction,
such that paths can be joined together on common vertices to give
rise to more complex semantic associations. Formally, a semantic
association is deﬁned as follows:
Given a directed graph G ¼ ðV ; EÞ, where V ¼ v0;v1; . . .vnf g is the
vertex set and E ¼ e0; e1; . . . ; emf g is the set of labeled edges, a
semantic association pðs;tÞ exists between the vertex (s) and the
vertex (t) if, for some arbitrary set of vertices Vp ¼ vp0 ;vp1 ; . . . ;

vpdg; Vp  V , for all vertex pairs ðv i;v jÞ in Vp, j = i + 1 or
j = i 1, for all 16 i6 d.
Using this notion of a semantic association, we can then exploit
the idea of reachability to generate semantic associations using the
predications graphs.
3.4.2. Reachability
Reachability is the notion of being able to get from one vertex to
some other vertex in a directed graph [35,38]. Given our deﬁnition
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tex s, if the two vertices are semantically associated. In general
terms, the set of all semantic associations between all pairs of ver-
tices ðv i;v jÞ in the vertex set V of the graph G, is the transitive clo-
sure (or reachability relation) of the entire graph G. However, for our
purposes we are only concerned with the transitive closure be-
tween the vertex pairs (s, t), where s = DFO and t = RS. Since there
are various manifestations of DFO and RS in the UMLS, to compute
this transitive closure we selected the following UMLS concepts:
Fish Oil – dietary (FOD), whose CUI,3 is C0556145 Fish Oils (FO),
whose CUI is C0016157 and Eicosapentaenoic Acid (EPA), whose
CUI is C0000545 as synonyms for DFO. Similarly, we used the con-
cept Raynaud Disease (RD), whose CUI is C0034734 and the concept
Raynaud Phenomenon (RP), whose CUI is C0034735 as synonyms for
RS. In the next Section, we formally deﬁne the reachability relation
between two vertices.
3.4.3. Reachability relation and predication selection
We obtained the transitive closure between a vertex pair using
the classical Depth First Search (DFS) algorithm to traverse the
predications graph according to our notion of a semantic associa-
tion. We set variants of DFO as the root and variants of RS as the
terminal. Hence, the input to the algorithm is various sets of
(DFO, RS) vertex pairs, and the output is a set of semantic associa-
tions or the reachability relation between the vertex pairs. Infor-
mally, the reachability relation is the subgraph formed by the
transitive closure between two vertices in a directed graph (ignor-
ing directionality), which is the set of all semantic associations (by
our deﬁnition) between the two vertices. Formally:
The Reachability Relation between the vertex pair (s, t), denoted
R, is a subgraph R ¼ ðVr ; ErÞ where R  GS(D), Vr  V and Er  E, such
that R is the transitive closure Pðs;tÞ ¼ p1; p2; . . . ; pkf g of associations
for the vertex pair (s,t), where pkðVrÞ is the vertex set of the kth
association in Pðs;tÞ, such that pkðVrÞ ¼ s ¼ vk0;vk1; . . . ;f
vkjpkðVr Þj ¼ tg for all ðv i;v jÞ and j = i + 1, or j = i  1, for all
1 6 i 6j pkðVrÞ j, and 1 6 k 6j Pðs;tÞ j.
We initially selected a maximum depth of 3 as a stopping con-
dition for the Depth First Search (DFS) algorithm, and observed a
maximum running time of 1 s to generate the reachability relation.
At depth 4, the maximum running time increased to 16 s, and at
depth 5, the maximum was 4 min. Empirically, our experiments
(discussed in Section 4) suggest that beyond the maximum depth
of 3, the associations returned by the algorithm while many, pro-
duce diminishing returns. Hence, we report here on associations
generated to the maximum depth of 3.
Further, to obtain these optimized running times, we excluded
associations containing generic concepts, such as ‘‘Disease’’ and
‘‘Patient.’’ The rationale is that such semantic predications are
not very insightful. For example, the two semantic predications
(Raynaud Disease ISA Disease) and (Raynaud Phenomenon PRO-
CESS_OF Patients) are not very informative. Given that (Epoprost-
enol TREATS Diseases) and (Raynaud Disease ISA Disease) is
certainly not sufﬁcient evidence to reasonably conclude that (Epo-
prostenol TREATS Raynaud Disease). By the same argument, we
also excluded associations containing semantic predications
involving weak predicates (of little relevance in this context), such
as PROCESS_OF, PROCESS_OF (SPEC), ADMINISTERED_TO, ADMIN-
ISTERED_TO (SPEC), PART_OF, ASSOCIATED_WITH, COEX-
ISTS_WITH, TREATS (INFER). We added the TREATS (INFER)
predicate to this set because, semantic predications containing
the TREATS (INFER) predicate are inherently weaker that those
containing the TREATS predicate. The stronger of these two is suf-3 Concept Unique Identiﬁer or CUI – a identiﬁed by a unique identiﬁer used to
distinguish UMLS concepts.ﬁcient. In the next Section, we discuss the creation of relevant sub-
graphs using the reachability relations extracted from the predica-
tions graphs, using the DFS algorithm.
3.5. Subgraph creation
We ﬁrst manually identiﬁed a number of associations articu-
lated by Swanson in his original RS-DFO paper [1]. To identify the
associations, we created chains of semantic predications based
on statements in the text. For example Swanson stated in the RS-
DFO paper [1], Section entitled: The Effects of Dietary Fish Oil on
Blood Viscosity, Platelet Function and Vascular Reactivity, page 4 that:
‘‘It is known that EPA can suppress platelet aggregation by several dif-
ferent mechanisms, though which among them are of greatest impor-
tance is not known.’’ From this sentence we created a semantic
predication which states that Dietary Fish Oil? INHIBITS? plate-
let aggregation, since EPA and Eicosapentaenoic acid are synony-
mous with dietary ﬁsh oil. The term ‘‘suppress’’ corresponds to
the UMLS predicate ‘‘INHIBITS,’’ and the term ‘‘platelet aggrega-
tion’’ is used as the object, since it is a known UMLS concept. By
chaining together such predications, we identiﬁed three primary
associations (shown in Table 3, ID: #1, #2, #3) involving platelet
aggregation, blood viscosity and vascular reactivity, which are
commonly discussed in biomedical literature and recognized as
Swanson’s RS-DFO hypothesis. Additionally, we identiﬁed eight
supplementary associations (Table 3, ID: 1a on platelet aggregation,
Table 3, ID: 2a-c on blood viscosity and Table 3, ID: 3a-d on vascu-
lar reactivity) which expound the primary associations in detail.
Then, we identiﬁed eight secondary associations (Table 5, ID: 1.1–
2, 2.1–3, and 3.1–3) which provide associations between other
concepts and RS (such as Ketanserin, Nifedipine and Alprostadil),
but do not necessarily link DFO and RS directly.
From the collection of all reachability relations, we then manu-
ally constructed subgraphs by grouping semantic associations
deemed relevant to each of Swanson’s original claims. We then in-
spected each subgraph (denoted GPDFSi ) and used domain expertise
to provide background knowledge when necessary. Since each sub-
graph from the DFS output either contains the same knowledge as
Swanson’s association (denoted pSi ) or requires background knowl-
edge for extrapolation, such a step was crucial.
The overall workﬂow of our approach is therefore to: (1) use the
SKR API to extract semantic predications using SemRep; (2) build a
predications graph from the SKR output, augmented with missing
semantic predications we manually added for vascular reactivity;
(3) use a DFS algorithm to traverse the predications graph to ex-
tract semantic associations between DFO and RS. The output of
the algorithm is a set of reachability relations for each (DFO, RS)
pair; (4) manually construct subgraphs by grouping associations
deemed relevant to each of Swanson’s original claims, using the
collection of reachability relations from the DFS algorithm; (5)
use domain expertise to add background knowledge to bridge
knowledge gaps among concepts, in scenarios when subgraphs
lack expressiveness.
Before discussing the experiments, we acknowledge the scala-
bility limitation in manually clustering associations into sub-
graphs, and using domain experts to infer background
knowledge. We anticipate in future work, the use of structural
graph-based features such as centrality, geodesic and clustering
coefﬁcient [39] as well as semantics-based features such as the
use of higher-order associations from ontology schemas [6,37],
concept class membership based on hierarchical and associative
relationships [35], as well as semantic similarity measures, to im-
prove scalability. Information-theoretic approaches such as infor-
mation gain could also be useful. To support automatic inclusion
of background knowledge, ideas such as knowledge abstraction
we presented in [35] could also be pivotal. In the next Section we
Table 2
Semantic association statistics.
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these steps.
4. Experimental results
In the ﬁrst experiment, we aim to show that Swanson’s associ-
ations can be recovered and decomposed using semantic predica-
tions, semantic associations, expressive subgraphs, background
knowledge and our graph-based techniques. Our results shows
that we recovered the three primary associations, and retrieved 4
of the 8 of the decomposed supplementary associations and also
7 of the 8 of the decomposed secondary associations. An interest-
ing observation in this process is that none of Swanson’s original
associations (primary or otherwise) occurred directly as individual
associations with the reachability relations. It turns out that aggre-
gating and clustering the associations was an imperative step in or-
der to arrive at any of Swanson’s conclusions.
For the rest of this Section and the following Subsections, in
each Figure solid black lines represent semantic predications that
directly appeared in the literature. Solid double green lines repre-
sent assertions made by abductive reasoning using the surround-
ing semantic predications in the subgraph, and broken blue lines
represent assertions gleaned from background knowledge. Also re-
call that Dietary Fish Oil (DFO) is used as reference for Fish Oils
(FO), Fish Oil – dietary (FOD), Eicosapentaenoic Acid (EPA).
4.1. Experiment I: Titles, abstracts and full text
For the ﬁrst experiment (based on full text articles from B1), we
found a total of 382 associations in the reachability relation, for
which Fish Oil – dietary (FOD) was the root. Among these, only
three associations terminated with RS (i.e., one with Raynaud Dis-
ease (RD = 1) and two with Raynaud Phenomenon (RP = 2) asTable 3
Primary and supplementary associations.
Intermediate ID Association
Platelet
aggregation
#1 Dietary Fish Oil? INHIBITS? platelet aggregation? CAUS
1a Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? IN
Blood viscosity #2 Dietary Fish Oil? INHIBITS? blood viscosity? CAUSES?
2a Dietary Fish Oil? INHIBITS? triglyceride? ISA? Blood L
2b Dietary Fish Oil? AUGMENTS? Erythrocyte Deformabilit
2c Dietary Fish Oil? INHIBITS? Serotonin? AUGMENTS?
Syndrome
Vascular
reactivity
#3 Dietary Fish Oil? INHIBITS? vascular reactivity? CAUSE
3a Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? CA
3b Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? IN
3c Dietary Fish Oil? PRODUCES? Prostaglandin (PGE1)? IN
aggregation? CAUSES? vasoconstriction? CAUSES? Ra
3d Dietary Fish Oil? INHIBITS? Serotonin? CAUSES? vasoshown in Table 2). We also found a total of 2124 associations for
which Fish Oils (FO) was the root of the reachability relation.
Among these only 14 terminated with RS (RD = 3, RP = 11). Then
we found another 17848 associations for which Eicosapentaenoic
Acid (EPA) was the root of the reachability relation, among which
172 terminated with RS (RD = 48, RP = 124). Hence, we found a to-
tal of 189 associations for which DFO was the root and RS was the
terminal.
To link these automatically generated associations with Swan-
son’s original associations, we manually selected relevant associa-
tion from these 189 associations, and constructed subgraphs for
comparison with each of the three primary associations (Table 3,
ID: #1, #2 and #3), eight supplementary associations (Table 3,
ID: 1a, 2a-c and 3a-d) and eight secondary associations (Table 5,
ID: 1.1–3, 2.1–2, 3.1–3) identiﬁed from Swanson’s paper. We begin
by comparing the subgraphs ðGPDFSi Þ and corresponding Swanson
association ðpSi Þ for platelet aggregation in the following Section.4.1.1. Platelet aggregation
The ﬁrst primary association Swanson established (repeated in
Table 4, ID: #1) was that (DFO INHIBITS platelet aggregation) and
high levels of (platelet aggregation CAUSES RS). Among the 189
automatically generated associations, eight associations (Table 4,
ID: 77, 78, 80, 81, 83, 84, 135 and 150) were deemed relevant to
this claim. We constructed the subgraph in Fig. 2 from these eight
associations, and used it to conclude that since (DFO STIMULATES
Epoprostenol) and Epoprostenol both DISRUPTS platelet aggrega-
tion and TREATS RS, then by abduction, perhaps (platelet aggrega-
tion CAUSES RS). If this is true, then (DFO TREATS RS) by
stimulating Epoprostenol which disrupts platelet aggregation and
thereby prevents RS.
From this example, it is clear that the integration of several
associations, to form subgraphs is necessary for recoveringES? Raynaud Syndrome
HIBITS? platelet aggregation? CAUSES? Raynaud Syndrome
Raynaud Syndrome
ipid? AFFECTS? blood viscosity? CAUSES? Raynaud Syndrome
y? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome
Erythrocyte Deformability? INHIBITS? blood viscosity? CAUSES? Raynaud
S? Raynaud Syndrome
USES? vasodilation? INHIBITS? Raynaud Syndrome
HIBITS? vasoconstriction? CAUSES? Raynaud Syndrome
HIBITS? platelet
ynaud Syndrome
constriction? CAUSES? Raynaud Syndrome
Table 4
Subgraphs for primary and supplementary associations.
Assoc. #1 Dietary Fish Oil? INHIBITS? platelet aggregation? CAUSES? Raynaud Syndrome
Subgraph 77 Eicosapentaenoic Acid DISRUPTS Platelet
aggregation
Epoprostenol DISRUPTS Platelet aggregation Epoprostenol TREATS Raynaud Disease
Epoprostenol TREATS Raynaud Phenomenon
78
80
81
83
84
135 Eicosapentaenoic Acid STIMULATES Epoprostenol
150
1a Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? INHIBITS? platelet aggregation? CAUSES? Raynaud Syndrome
Subgraph 37 Eicosapentaenoic Acid CONVERTS TO Prostaglandin
I3
prostaglandin I3 ISA Epoprostenol Epoprostenol TREATS Raynaud Disease
Epoprostenol TREATS Raynaud Phenomenon
38
40 Eicosapentaenoic Acid CONVERTS TO
Prostaglandins
Epoprostenol ISA Prostaglandins
41
77 Eicosapentaenoic Acid DISRUPTS Platelet
aggregation
Epoprostenol DISRUPTS Platelet aggregation
78
80 Epoprostenol INHIBITS_MAN Platelet
aggregation
81
83 Epoprostenol PREVENTS_MAN Platelet
aggregation
84
135 Eicosapentaenoic Acid STIMULATES Epoprostenol
150
#2 Dietary Fish Oil? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome
Subgraph 71 Eicosapentaenoic Acid DISRUPTS blood viscosity Ketanserin DISRUPTS blood viscosity Ketanserin TREATS Raynaud Phenomenon
175 Fish Oils AFFECTS blood viscosity
135 Eicosapentaenoic Acid STIMULATES Epoprostenol Epoprostenol TREATS Raynaud Disease
150 Epoprostenol TREATS Raynaud Phenomenon
2a Dietary Fish Oil? INHIBITS? triglyceride? ISA? Blood Lipid? AFFECTS? blood viscosity? CAUSES? Raynaud Syndrome
Subgraph 71 Eicosapentaenoic Acid DISRUPTS blood viscosity Ketanserin DISRUPTS blood viscosity Ketanserin TREATS Raynaud Phenomenon
175 Fish Oils AFFECTS blood viscosity
135 Eicosapentaenoic Acid STIMULATES Epoprostenol Epoprostenol TREATS Raynaud Disease
Epoprostenol TREATS Raynaud Syndrome
150
111 Eicosapentaenoic Acid ISA Fatty Acids Epoprostenol STIMULATES Fatty Acids
112
. 2b Dietary Fish Oil? AUGMENTS? Erythrocyte Deformability? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome
2c Dietary Fish Oil? INHIBITS? Serotonin? AUGMENTS? Erythrocyte Deformability? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome
#3 Dietary Fish Oil? INHIBITS? vascular reactivity? CAUSES? Raynaud Syndrome
Subgraph 25 Eicosapentaenoic Acid AFFECTS_MAN Vascular
constriction
Epoprostenol INHIBITS_MAN Vascular
constriction
Epoprostenol TREATS Raynaud Disease
26 Epoprostenol TREATS Raynaud Phenomenon
3a Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? CAUSES? vasodilation? INHIBITS? Raynaud Phenomenon
3b Dietary Fish Oil? PRODUCES? Prostaglandin (PGI3)? INHIBITS? vasoconstriction? CAUSES? Raynaud Phenomenon
Subgraph 25 Eicosapentaenoic Acid AFFECTS_MAN Vascular
constriction
Epoprostenol INHIBITS_MAN Vascular
constriction
Epoprostenol TREATS Raynaud Disease
Epoprostenol TREATS Raynaud Phenomenon
26
66 Eicosapentaenoic Acid CONVERTS_TO prostaglandin
I3
prostaglandin I3 ISA Epoprostenol
67
37 Eicosapentaenoic Acid CONVERTS_TO
Prostaglandins
Epoprostenol ISA Prostaglandins
38
3c Dietary Fish Oil? PRODUCES? Prostaglandin (PGE1)? INHIBITS? platelet aggregation? CAUSES? vasoconstriction? CAUSES? Raynaud
Syndrome
3d Dietary Fish Oil? INHIBITS? Serotonin? CAUSES? vasoconstriction? CAUSES? Raynaud Syndrome
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the construction of such subgraphs can be semi-automated by
automatically extracting the relevant semantic associations. We
believe that the future of LBD will beneﬁt from ability to fully auto-
mate the creation of such subgraphs.Next, the only supplementary association involving DFO, RS,
platelet aggregation (Table 3 and Table 4 ID: 1a) that Swanson de-
scribed, claims that (DFO PRODUCES Prostaglandin ðPGI3Þ) and
(Prostaglandin ðPGI3Þ INHIBITS platelet aggregation) and (platelet
aggregation CAUSES RS). Twelve associations (Table 4 ID: 1a,
Fig. 2. Primary association subgraph: platelet aggregation.
Fig. 3. Supplementary association subgraph: platelet aggregation.
Table 5
Secondary associations.
Assoc. 1.1 Prostaglandin (PGE1)? INHIBITS? platelet aggregation? CAUSES? Raynaud Syndrome
Subgraph 73 Eicosapentaenoic Acid DISRUPTS Platelet
aggregation
Alprostadil DISRUPTS Platelet aggregation Alprostadil INTERACTS_WITH Raynaud Disease
1.2 Prostacyclin (PGI2)? INHIBITS? platelet aggregation? CAUSES? Raynaud Syndrome
Subgraph 77 Eicosapentaenoic Acid DISRUPTS Platelet
aggregation
Epoprostenol DISRUPTS Platelet aggregation Epoprostenol TREATS Raynaud Disease
Epoprostenol TREATS Raynaud Phenomenon
78
80 Epoprostenol INHIBITS_MAN Platelet
aggregation
81
83 Epoprostenol PREVENTS_MAN Platelet
aggregation
84
135 Eicosapentaenoic Acid STIMULATES Epoprostenol
150
1.3 Nifedipine? ISA? CCB? INHIBITS? platelet activation? ASSOCIATED_WITH? Raynaud Syndrome
Subgraph 91 Eicosapentaenoic Acid DISRUPTS Platelet function Nifedipine DISRUPTS Platelet function Nifedipine TREATS Raynaud Phenomenon
140 Eicosapentaenoic Acid STIMULATES Epoprostenol Epoprostenol TREATS Raynaud Phenomenon
2.1 Prostacyclin (PGI2)? AUGMENTS? Erythrocyte Deformability? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome (in vitro)
Subgraph 71 Eicosapentaenoic Acid DISRUPTS blood viscosity Ketanserin DISRUPTS blood viscosity Ketanserin TREATS Raynaud Phenomenon
175 Fish Oils AFFECTS blood viscosity
135 Eicosapentaenoic Acid STIMULATES Epoprostenol Epoprostenol TREATS Raynaud Disease
150 Epoprostenol TREATS Raynaud Phenomenon
2.2 Ketanserin? INHIBITS? serotonin? AUGMENTS? Erythrocyte Deformability? INHIBITS? blood viscosity? CAUSES? Raynaud Syndrome
Subgraph 71 Eicosapentaenoic Acid DISRUPTS blood viscosity Ketanserin DISRUPTS blood viscosity Ketanserin TREATS Raynaud Phenomenon
175 Fish Oils AFFECTS blood viscosity
3.1 Prostaglandin (PGE1)? CAUSES? vasodilation? INHIBITS? Raynaud Syndrome
3.2 Prostacyclin (PGI2)? CAUSES? vasodilation? INHIBITS? Raynaud Syndrome
Subgraph 25 Eicosapentaenoic Acid AFFECTS_MAN Vascular
constriction
Epoprostenol INHIBITS_MAN Vascular
constriction
Epoprostenol TREATS Raynaud Disease
26 Epoprostenol TREATS Raynaud Phenomenon
3.3 Nifedipine? ISA? Calcium Channel Blocker? CAUSES? vasodilation? INHIBITS? Raynaud Syndrome
Subgraph 35 Eicosapentaenoic Acid AFFECTS_MAN Vascular
constriction
Nifedipine INHIBITS_MAN Vascular
constriction
Nifedipine TREATS Raynaud Phenomenon
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Fig. 4. Primary association subgraph: blood viscosity.
Fig. 5. Supplementary association subgraph: blood viscosity.
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subgraph in Fig. 3 was constructed. This subgraph shows that
(Eicosapentaenoic Acid CONVERTS_TO Prostaglandin ðPGI3Þ) and
(Prostaglandin ðPGI3Þ ISA Epoprostenol). Since it was inferred from
the previous subgraph in Fig. 2 that (Epoprostenol TREATS RS) by
disrupting platelet aggregation, by abduction we can surmise that
Prostaglandin ðPGI3Þ also TREATS RS by disrupting platelet aggre-
gation, because Prostaglandin ðPGI3Þ is also a Prostaglandin. Fur-
thermore, since Epoprostenol is a member of the Prostaglandin
family, we can also infer that (DFO TREATS RS) by producing Pros-
taglandin, which DISRUPTS platelet aggregation. This conclusion is
supported by the ﬁrst secondary association (Table 5, ID: 1.1 and
73) in which Swanson claims that another Prostaglandin ðPGE1Þ
(also called Alprostadil) also TREATS RS by inhibiting platelet
aggregation.
Swanson also presented another secondary association (Table 5,
ID: 1.3) in which the drug Nifedipine, which ISA Calcium Channel
Blocker, inhibits platelet activation and so TREATS RS. We found
one association (Table 5, ID: 91) which states that (Nifedipine DIS-
RUPTS Platelet function). We also found a second association (Ta-
ble 5, ID: 140) which states that (Nifedipine TREATS Raynaud
Phenomenon). Since (Prostaglandin TREATS RS) by inhibiting
platelet aggregation we can also surmise by abduction that Nifed-
ipine also TREATS Raynaud Phenomenon as a result of disrupting
platelet function. That (Nifedipine ISA Calcium Channel Blocker)
would be obtained from background knowledge.4.1.2. Blood viscosity
The second primary association between DFO and RS (Table 3,
ID: 2), claims that (DFO INHIBITS blood viscosity) and (blood vis-
cosity CAUSES RS). We found four associations (Table 4, ID: 71,135, 150 and 175) deemed relevant to this claim, and from them
constructed the subgraph in Fig. 4.
When we apply Hristovski’s discovery pattern from [17] to this
subgraph, we can surmise by adbuction that if (Epoprostenol
TREATS RS) and (Ketanserin TREATS RS), given that (Ketanserin
DISRUPTS blood viscosity), then perhaps (Epoprostenol TREATS
RS) by also disrupting blood viscosoty. If this is true, it follows that
(DFO DISRUPTS blood viscosity) by producing Epoprostenol. We
can therefore conjecture that blood viscosity may be another cause
of RS.
Swanson’s ﬁrst supplementary association (Table 4, ID: 2a) in
which (DFO TREATS RS) through blood viscosity claims that DFO
inhibits various blood lipids (speciﬁcally triglycerides) which di-
rectly or indirectly increase blood viscosity. We found six associa-
tions (Table 4, ID: 71, 111, 112, 135, 150, 175) deemed relevant to
this observation and constructed the subgraph in Fig. 5. From this
subgraph, we observe that (DFO ISA Fatty Acid) and (DFO also DIS-
RUPTS blood viscosity). However, from background knowledge
[40], it is known that DFO is an essential fatty acid which is known
to exhibit several health beneﬁts. One major beneﬁt of fatty acids is
the inhibition of triglycerides (also a Lipid). This inhibition AF-
FECTS blood viscosity. It follows by abduction that (DFO TREATS
RS) by inhibiting lipids and thereby lowering blood viscosity.
This example clearly establishes the need for background
knowledge, whether explicit from an ontology or using domain ex-
perts to bridge the knowledge gap needed to make scientiﬁc dis-
coveries from scientiﬁc literature. It highlights the third point
put forth in the Conclusion Section of the abstract, which states that
a critical aspect of semantics-based LBD will depend in future on
the semantic integration of background knowledge for interpretation.
Swanson further discussed two additional supplementary asso-
ciations in which (DFO INHIBITS blood viscosity). In the ﬁrst (Ta-
Fig. 6. Primary association subgraph: vascular reactivity.
Fig. 7. Supplementary association subgraph:vascular reactivity.
248 D. Cameron et al. / Journal of Biomedical Informatics 46 (2013) 238–251ble 4, ID: 2b), he claims that DFOs inﬂuence the ability of red blood
cells to alter their shape under ﬂuid pressure. That is, (DFO AUG-
MENTS Erythrocyte Deformability) and (Erythrocyte Deformability
INHIBITS blood viscosity), and high (blood viscosity CAUSES RS). In
the other supplementary association (Table 4, ID: 2c) Swanson
claims that (DFO INHIBITS Serotonin) and it is this inhibition that
AUGMENTS Erythrocyte Deformability. Unfortunately, we did not
recover any of these two associations.
Finally, Swanson also discussed another secondary association
involving blood viscosity (Table 5, ID: 2.2) in which (Ketanserin
INHIBITS Serotonin) and hence AUGMENTS Erythrocyte Deforma-
bility. While this association was not recovered at this level of
granularity, two associations (Table 5, ID: 71, 175) provided evi-
dence that (Ketanserin TREATS RS) by inhibiting blood viscosity.
4.1.3. Vascular reactivity
Swanson’s third primary association (Table 3, Table 4, ID: #3)
claims that (DFO TREATS RS) by inhibiting vascular reactivity
(i.e., vasoconstriction, Vascular constriction (function)) which
causes RS. We found two relevant associations (Table 4, ID: 25,
26) from which the subgraph shown in Fig. 6 was constructed. This
subgraph shows that (Eicosapentaenoic Acid AFFECTS_MAN Vascu-
lar constriction (function)) and (Epoprostenol INHIBITS_MAN Vas-
cular constriction (function)) and (Epoprostenol TREATS RS). Since,
we know that DFO STIMULATES Epoprostenol, and Epoprostenol
also INHIBITS vasoconstriction and also TREATS RS, we can again
conjecture by adbuction that perhaps (vasoconstriction CAUSES
RS).
The ﬁrst supplementary association involving vasoconstriction
(Table 4, ID: 3a) states that (DFO PRODUCES PGI3Þ and (PGI3
CAUSES vasodilation), and vasodilation INHIBITS RS. The second
supplementary association (Table 4, ID: 3b) is similar, except that
it states that (PGI3 also INHIBITS vasoconstriction) and therefore
INHIBITS RS. We found six associations (Table 4, ID: 25, 26, 37,
38, 66, 67) deemed relevant to this association. From them we sur-
mized that perhaps (Epoprostenol TREATS RS) by inhibiting vaso-
constriction. If (DFO PRODUCES Prostaglandin ðPGI3Þ) and
(Prostaglandin ðPGI3Þ ISA Epoprostenol), given that (EpoprostenolINHIBITS vasoconstriction), Prostaglandin ðPGI3Þ possibly also
INHIBITS vasoconstriction. Hence, it may be the case that (Epo-
prostenol TREATS RS) by inhibiting vasoconstriction.
We did not recover the third or fourth supplementary associa-
tions (Table 4, ID: 3c, 3d), hence we found no evidence that (Pros-
taglandin ðPGE1Þ CAUSES vasoconstriction) by inhibiting platelet
aggregation.
Finally, Swanson also discussed several secondary associations
involving vascular reactivity and RS. Again, we could not recover
the secondary association in Table 5, ID: 3.1, due the absence of
predication which states that (Prostaglandin ðPGE1Þ CAUSES
vasoconstriction).
For the secondary association in Table 5, ID: 3.2, we found two
associations (Table 5, ID: 25), 26 from which we conjectured by
abduction that since (Epoprostenol INHIBITS vasoconstriction) by
inference (Epoprostenol CAUSES vasodilation) which (INHIBITS
RS). For the last secondary association (Table 5, ID: 3.3), we found
one association (Table 5, ID: 35) from which we conjectured that
since (Nifedipine INHIBITS vasoconstriction) it CAUSES vasodila-
tion which INHIBITS RS. From background knowledge, it is known
that (Nifedipine ISA Calcium Channel Blocker). In the next Section,
we discuss the results for our second experiment which used only
titles and abstracts.
4.2. Experiment II: Titles and abstracts only
In the second experiment, we aim determine to what extent ti-
tles and abstracts may be adequate for supporting LBD, if indeed
that are adequate at all. After applying the DFS algorithm to the
predications from the B2 dataset, we found 22 associations for
which Fish Oil – dietary (FOD) was the root of the reachability rela-
tion. However no associations terminated with RS (RD = 0, RP = 0)
as shown in Table 2. We also found a total of 67 associations for
which Fish Oils (FO) was the root of the reachability relation,
among which two terminated with RS (RD = 0, RP = 2). Finally,
we also found another 224 associations, for which Eicosapentae-
noic Acid (EPA) was the root of the reachability relation, among
which 34 terminated with RS (RD = 8, RP = 26). Hence, we found
Fig. 8. Primary association subgraph: platelet aggregation (Exp2).
Fig. 9. Supplementary association subgraph: platelet aggregation (Exp2).
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the terminal. We again manually constructed the subgraphs and
compared them with Swanson’s original claims (see Fig. 7).
4.2.1. Platelet aggregation
For Swanson’s ﬁrst primary association (Table 3, ID: 1), four
associations (available online)4 among these 36 associations were
deemed relevant. We constructed the subgraph in Fig. 8 from these
associations, but no direct link between DFO and platelet aggrega-
tion was observed. Instead, two novel associations were found.
Unfortunately, the absence of a direct link to platelet aggregation
made it difﬁcult to infer the role of DFO and platelet aggregation
in treating RS. This indicates that the B2 dataset may not contain suf-
ﬁcient information to support recovery of Swanson’s associations.
For the ﬁrst supplementary association (Table 3, Table 5, ID: 1a)
involving platelet aggregation, we found four of the eight associa-
tions from the ﬁrst experiment. However, no direct association ex-
isted between DFO and platelet aggregation in the subgraph shown
in Fig. 9. While, we can conjecture that (DFO TREATS RS) through
Prostaglandins from the two associations which state that (DFO
PRODUCES Prostaglandin PGI3) and (Epoprostenol ISA Prostaglan-
din), the role of platelet aggregation is still not apparent.
Similarly for the secondary associations (Table 5, ID: 1.1, 1.2,
1.3), although there is sufﬁcient information to surmize that
(DFO TREATS RS), the role of platelet aggregation is again obscured.
4.2.2. Blood viscosity
For Swanson’s second primary association involving blood vis-
cosity (Tables 3, 5, ID: 2), we found virtually the same four associ-
ations as in experiment 1. The main difference was that for two of
the four associations, we found that (Ketanserin AFFECTS blood
viscosity), instead of (Ketanserin DISRUPTS blood viscosity). From
the subgraph in Fig. 10, we can conclude that (DFO TREATS RS)
by lowering blood viscosity, on the assumption that (Ketanserin
AFFECTS blood viscosity) is synonymous with (Ketanserin DIS-4 Datasets – http://wiki.knoesis.org/index.php/Obvio#RS-DFO_Hypothesis.RUPTS blood viscosity) and by applying Hristovski’s discovery pat-
tern to infer that Epoprostenol also DISRUPTS blood viscosity.
By contrast however, for Swanson’s ﬁrst supplementary associ-
ation (Table 4, ID: 2a), we recovered four associations out of six
associations from experiment 1. The critical association between
DFO and fatty acids which states that (Eicosapentaenoic Acid ISA
Fatty Acids) and (Epoprostenol STIMULATES Fatty Acids) are nota-
bly absent. It was difﬁcult to make the association that (DFO
TREATS RS) by inhibiting blood viscosity.
4.2.3. Vascular reactivity
There were two distinct mentions of vascular reactivity in the
B2 dataset, from which one predication was manually identiﬁed,
that is, (vasoconstriction ASSOCIATED_WITH Eicosapentaenoic
Acid). Unfortunately this was insufﬁcient for linking DFO and RS
through vascular reactivity. Hence, no associations were recovered
using the B2 dataset.
This result seems to suggests that titles and abstracts alone,
might NOT be sufﬁcient to rediscover Swanson’s hypothesis, hence
raising concerns about their adequacy for Literature-Based Discov-
ery (LBD) in general.5. Discussion
Our graph-based framework leverages semantic representa-
tions to recover and decompose Swanson’s Raynaud Syndrome–Fish
Oil hypothesis. To the best of our knowledge, this is the ﬁrst at-
tempt at decomposing Swanson’s primary associations into sup-
plementary and secondary associations (shown in Table 6). We
therefore exceed the state-of-the-art in semantics-based ap-
proaches for recovering Swanson’s RS-DFO hypothesis [17,30] in
terms of context, coverage, and expressiveness of associations,
while providing insight into some prerequisites for semantics-
based LBD.
However, while an improvement over the state-of-the-art, our
graph and semantics-based approach is far from foolproof. This
anecdotal example using Swanson’s RS-DFO hypothesis, circum-
vents many limitations that exist when using large corpora and
background knowledge sources for open discovery.
5.1. Limitations
The ﬁrst limitation is the unavailability of the relevant datasets
that contain adequate information to support LBD. While MEDLINE
provides titles and abstracts for more than 20 million scientiﬁc
articles, it is unclear to what extent this can be exploited for LBD.
Experiment 2 shows compelling evidence that many of the associ-
ations recovered in Experiment 1, which were critical for reasoning
were unavailable in the titles and abstracts in the second experi-
ment. This becomes a major problem when addressing open dis-
covery, given the full text articles may be unavailable. The
concern is that ‘‘hidden information may remain hidden’’ in full text
throughout the corpus.
The second limitation is the ability to extract semantic informa-
tion from the selected literature [31]. As evidenced by the vascular
reactivity scenario, the inability to extract some semantic predica-
tions presents a major bottleneck. While we avoided this problem
owing to manual annotations on this small dataset, semantic infor-
mation extraction becomes a serious problem on the large scale.
The third issue is devising techniques to avoid the combinato-
rial explosion that arises when traversing large data graphs. Many
query execution platforms will time-out, due to memory limita-
tions, and return no results on large graphs. While, graph traversal
can be propagated based on as structural graph properties [39], the
need to exploit semantics is crucial. Semantics-based techniques
Table 6
Comparison of semantics-based techniques for recovering and decomposing Swan-
son’s associations.
Association type Swanson Cameron et al. State-of-the-art
Primary 3 3 2
Supplementary 8 4 0
Secondary 8 7 0
Fig. 10. Primary association subgraph: blood viscosity (Exp2).
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[41,35], but their effectiveness for open discovery scenarios has
not yet been realized.
Furthermore, another issue is deriving scalable techniques for
extracting relevant semantic associations between concepts, and
then aggregating such associations to form subgraphs. Subgraph
creation is crucial for sense making, question answering and ulti-
mately LBD. While we anticipate that the extraction of semantic
associations can be based on the notion of q-isomorphism [6] and
information theory [42], semantic association extraction from
large data graph is still a major problem. Popular pattern-based ap-
proaches [17,30,19] are not scalable, while structural graph-based
approaches [16,28,20] tend to lack both coverage and
expressiveness.
Beyond the extraction of semantic associations from large data
graphs and the automatic creation of subgraphs from those associ-
ations, perhaps the most signiﬁcant challenge is incorporating
background knowledge from structured sources to enhance sub-
graphs to bridge knowledge gaps when subgraphs themselves
prove insufﬁcient. Aside from work by Cameron et al. [35], the
semantic integration of scientiﬁc literature and background is con-
sidered next generation research and thus remains largely unex-
plored. Although Russ et al. [43] developed KEfED for the
semantic integration of background knowledge and other knowl-
edge sources, the focus is primarily on experimental data rather
than scientiﬁc literature.
Finally, another major issue is resolving inconsistencies arising
during the semantic predication extraction. For instance, both
(Eicosapentaenoic Acid INHIBITS Epoprostenol) and (Eicosapentae-
noic Acid STIMULATES Epoprostenol) were observed from the Sem-
Rep output. Such discrepancies must be resolved at some level, if a
robust graph-based semantic system for LBD can be created.
5.2. Contribution
In spite of these limitations, we showed that semantic predica-
tions, semantic associations, subgraphs, background knowledge
and our graph-based techniques are important elements for LBD.
Our results advance the standard established by the state-of-the-
art when recovering and decomposing Swanson’s RS-DFO hypoth-
esis using these constructs. This suggests that a critical feature ofnext generation LBD is the semantic integration of scientiﬁc litera-
ture with background knowledge.5.3. Implications
A fully mature system implemented based on our methodology,
could be used as follows. Through a web interface, a user may se-
lect a concept from the predications graph, then browse intuitively
along an association. After reaching a suitable target, the user can
select an option to generate a subgraph of associations related to
the current association. Concurrently, the system will present the
related predications from the background knowledge source that
logically connect disjoint concepts within the generated subgraph.
Such functionalities we believe will be signiﬁcant in aiding LBD.6. Conclusion
We presented a graph-based methodology for LBD that uses
semantic predications, semantic associations, expressive sub-
graphs and background knowledge to recover and decompose
Swanson’s Raynaud Syndrome-Fish Oil hypothesis. We are the ﬁrst
to put into perspective the shift in critical constructs for LBD, from
term co-occurrence and the ABC model, to semantic predications,
semantic associations (using the AnC model), subgraphs and back-
ground knowledge. We are also the ﬁrst to conduct an in-depth
decomposition of Swanson’s hypothesis based on this shift result-
ing in the retrieval of 14 out of the 19 associations, including 3 of
the 3 primary associations, 4 of the 8 supplementary associations
and 7 of the 8 secondary associations. In this process, we estab-
lished that the use of graph-based techniques together with
semantic representations to recover and decompose Swanson’s
hypothesis as well as to support LBD in general could beneﬁt from:
(1) expressive semantic representations beyond Swanson’s ABC
model; (2) an ability to accurately extract semantic information
from text; and (3) an ability to semantically integrate background
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